Navigation Links
Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015
Date:9/2/2015

NEW YORK, Sept. 2, 2015 /PRNewswire/ -- Seeger Weiss LLP is reporting that Zimmer Holdings Inc.'s NexGen knee implant bellwether trial will commence October 13, 2015.

Since the product was approved in 1995 using the 510K fast-track approval program, Zimmer NexGen knee implant surpassed FDA investigation and mandatory product testing. The program only requires that companies provide evidence that the product is substantially similar to a preexisting and approved product in order to gain permissions.

In 2001, Zimmer began distributing High Flex NexGen knee implants which were an updated version of the NexGen implants. The new Zimmer knee devices were supposed to provide patients with a wider range of motion, but many claims have been made that defective High Flex knee implants caused increased pain, loosening of the device, premature knee implant failure, and expensive revision surgery.

Currently, over one thousand cases have been consolidated in a multidistrict litigation in the Northern District of Illinois. The upcoming bellwether trials are intended to give plaintiffs and their attorneys in the remaining number of cases a better idea as to how juries will respond to certain evidence and testimonies that will be recurring throughout all similar trials.

Seeger Weiss LLP is currently investigating Zimmer Holdings, Inc. knee implants. If you believe you have been injured due to defective knee implants or wish to learn more, go to our NexGen Lawsuit page.

Seeger Weiss LLP is one of the nation's leading trial law firms handling complex individual, mass and class action litigation on behalf of consumers, investors, injured persons and whistleblowers. The firm, with offices in New York, Philadelphia and New Jersey, represents plaintiffs throughout litigation and as trial counsel in a variety of practice areas, including financial, securities and investment fraud, pharmaceutical injury, consumer protection, qui tam (whistleblower cases), environmental and asbestos exposures, personal injury and medical malpractice, product defect, antitrust, and commercial disputes. For more information, go to www.seegerweiss.com.

http://ryortho.com/breaking/zimmer-and-nexgen-go-on-trial-in-october/

http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-August-17-2015.pdf

Contact: 
Christopher A. Seeger, (212) 584-0700 or cseeger@seegerweiss.com 
Jeffrey S. Grand (212) 584-0700 or jgrand@seegerweiss.com

Logo - http://photos.prnewswire.com/prnh/20150527/218876LOGO


'/>"/>
SOURCE Seeger Weiss LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Seeger Weiss LLP Is Investigating The Risk Of Diabetic Ketoacidosis Linked With Use Of Invokana
2. Seeger Weiss LLP Reports On A New Study Warning Of Potential Risk With Xarelto In Pregnant Patients
3. Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard
4. WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders
5. WeissLaw LLP: Unilens Vision, Inc. Acquisition By Valeant Pharmaceuticals International, Inc. May Not Be In The Best Interest Of UVIC Shareholders
6. Richard M. Weissman joins Diomics Board of Directors
7. WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition
8. WeissLaw LLP: The Auspex Pharmaceuticals, Inc. Acquisition by Teva Pharmaceutical Industries Is the Subject of a Legal Investigation
9. WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders
10. MEI Pharma Reports Fiscal Year 2015 Results
11. China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2019)... , ... October 19, 2019 , ... Hospital M&A activity ... according to new acquisition data from HealthCareMandA.com. The most recent quarter was down 20% ... was up sharply compared with the second quarter, totaling nearly $5.0 billion, a 291% ...
(Date:10/17/2019)... ... October 17, 2019 , ... The findings of a ... in the individuals studied could be caused by toxic chemicals rather than the inhalation ... Illness Associated With E-Cigarette Use (Vaping): A Report of Eight Cases ,” by Sanjay ...
(Date:10/15/2019)... ... ... Twiggy Bean, Ph.D., wanted to educate others about the divorce bullying epidemic ... and become truly child focused. This objective prompted her to write “Divorce Bullying: An ... Don’t be a divorce bully!” (published by Balboa Press), a guidebook that serves as ...
Breaking Medicine Technology:
(Date:10/15/2019)... RICHMOND, Calif. (PRWEB) , ... October 14, 2019 , ... ... Network West to ride atop the Donate Life Rose Parade® float in the ... impacted by organ and tissue donation across Northern California and Northern Nevada, the organization’s ...
(Date:10/15/2019)... ... October 15, 2019 , ... Labeling for Prescription Drugs, ... **An FDAnews Webinar**, Tuesday, October 29, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/labelpredrug, ... new drug applications and biologics license applications? , How will the current content ...
(Date:10/15/2019)... ... October 15, 2019 , ... Genomenon® announced today at ... GENETICS that includes incorporating the Mastermind® Genomic Search Engine into the ... genomic research at the fingertips of clinical researchers performing genomic analysis worldwide. ...
(Date:10/11/2019)... ... ... Only 6% of orthopedic surgeons in the country are women – and ... the sports medicine program. These four work with a whole host of women providing ... , Orthopedic medicine deals with the correction of differences in bones or ...
(Date:10/11/2019)... ... ... A Topping Out event was hosted today at the construction site of the Southwest ... event celebrated reaching the final height of the structure set to open in the ... in Texas, STA’s facility will be home to an organ recovery center including a ...
Breaking Medicine News(10 mins):